Ebos Group (ASX:EBO) Retained Earnings: A$519 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EBO Ebos Group Ltd ASX:EBO
80 GF Score
Price A$18.99
GF Value A$31.56
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ebos Group Retained Earnings?

Ebos Group ASX:EBO +0.74% 80 Retained Earnings is A$519 Mil as of Dec. 2025. GuruFocus rates ASX:EBO with a GF Score™ of 80/100 and a GF Value™ of A$31.56 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Ebos Group's retained earnings for the quarter that ended in Dec. 2025 was A$519 Mil.

Ebos Group's quarterly retained earnings declined from Dec. 2024 (A$528 Mil) to Jun. 2025 (A$501 Mil) but then increased from Jun. 2025 (A$501 Mil) to Dec. 2025 (A$519 Mil).

Ebos Group's annual retained earnings declined from Jun. 2023 (A$557 Mil) to Jun. 2024 (A$531 Mil) and declined from Jun. 2024 (A$531 Mil) to Jun. 2025 (A$501 Mil).


Ebos Group  (ASX:EBO) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Ebos Group Retained Earnings Historical Data

* Premium members only.

The historical data trend for Ebos Group's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ebos Group Retained Earnings Chart

Ebos Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 432.96 482.82 556.51 530.78 501.13

Ebos Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 493.39 530.78 527.69 501.13 519.05
ASX:EBO
80GF Score
Ebos Group Ltd ASX:EBO
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ebos Group Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of A$519 Mil mean?
Ebos Group (ASX:EBO) has a Retained Earnings of A$519 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Ebos Group and its competitors.
Is Ebos Group's Retained Earnings too high?
Ebos Group's current Retained Earnings is A$519 Mil. Overall, Ebos Group has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Retained Earnings compare to MCK and CAH?
Ebos Group's Retained Earnings of A$519 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Distribution company?
A good Retained Earnings depends on the Medical Distribution industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Ebos Group and its competitors. Ebos Group's current Retained Earnings is A$519 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.56, compared to a current price of A$18.99 — trading 39.8% below its estimated fair value. The current Retained Earnings is A$519 Mil. Ebos Group's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Retained Earnings is A$519 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ebos Group (ASX:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of A$18.99 is trading 39.8% below its estimated GF Value™ of A$31.56. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for ASX:EBO:

  • Retained Earnings: A$519 Mil
  • GF Value™: A$31.56 vs. price of A$18.99 (39.8% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
80GF Score

Get the complete analysis for ASX:EBO

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$18.99
Price
A$31.56
GF Value